Adient (ADNT) EBITDA (2015 - 2026)

Adient (ADNT) has reported EBITDA for 12 consecutive years, with $94.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 6.93% year-over-year to $94.0 million; the trailing twelve-month figure through Jun 2026 stood at $383.0 million (up 857.5% YoY), and the FY2025 full-year result was $47.0 million, down 81.42% from the prior year.
• EBITDA slipped to $94.0 million in Q2 2026 per ADNT's latest filing, from $114.0 million in the prior quarter.
• Across five years, EBITDA topped out at $148.0 million in Q2 2023 and bottomed at -$234.0 million in Q1 2025.
• Historically, EBITDA has averaged $65.9 million across 5 years, with a median of $90.0 million in 2023.
• The sharpest annual moves came in 2022 and 2025: EBITDA surged 1128.57% in 2022, then plunged 2240.0% in 2025.
• Over 5 years, EBITDA stood at $86.0 million in 2022, then rose by 2.33% to $88.0 million in 2023, then declined by 22.73% to $68.0 million in 2024, then retreated by 7.35% to $63.0 million in 2025, then soared by 49.21% to $94.0 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $94.0 million, $114.0 million, and $63.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.